Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.41NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.37.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FD.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.80NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBKNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.14.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-14980.9Singapore
XBK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DF.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used